Time |
Room |
|
Activity |
08:00-09:30 | Room 1 - Alfredo Halpern | SESSION: THE LANCET COMMISSION ON THE DEFINITION OF CLINICAL OBESITY: BACKGROUND, OBJECTIVES AND PROGRESS REPORT 15 | Background to the Lancet CommissionSpeaker: Ricardo Vitor Cohen (SP) 15 | The pathophysiology of obesity as a discrete disease 15 | BMI as a clinical and epidemiological instrumentSpeaker: Ricardo Vitor Cohen (SP) 15 | BMI and obesity considerations in paediatric populations 30 | Discussion |
08:00-09:30 | Room 2 - John Waterlow | SESSION: PATIENT REPORTED OUTCOMES MEASURES – IMPORTANCE IN CLINICAL PRACTICE AND RESEARCH 20 | How to measure quality of life improvement in clinical practice? 20 | ICHOM Set of Patient-Centred Outcome Measures for Adults living with Obesity 20 | Treating obesity beyond weight loss: what matters more for patients? Speaker: Amber Huett-garcia (United States) 30 | Discussion |
08:00-09:30 | Room 3 - Bernard Jeanrenaud | SESSION: WEIGHT CYCLING 8 | Abstracts - 129084: SERVICE EVALUATION OF A TIER 3, INTEGRATED WEIGHT MANAGEMENT PATHWAY USING SAXENDA (LIRAGLUTIDE) AND ITS IMPACT ON REDUCING CARDIOVASCULAR RISK FACTORS FOR PEOPLE LIVING WITH OBESITY - Presenter: Sophie Edwards 20 | Animal models of weight cyclingSpeaker: Marciane Milanski (SP) 20 | Epidemiology of weight cycling and comorbidities: correlation or causation? 20 | Weight cycling with newer AOMs: a new concern? 22 | Discussion |
08:00-09:30 | Room 5 - Phillip James | SESSION: THE HEALTH SYSTEM RESPONSE TO THE OBESITY EPIDEMIC 12 | Intersectoral and multistakeholder approach, with the participation of people with lived experience, as a way out of the obesity pandemic 12 | HIV as a model of care for obesity in the health systems 12 | The health system response to the obesity epidemic 12 | Health service delivery framework for obesity care: an integrated, interprofessional, and network approach 12 | Integrating lived experience in rethinking obesity treatment in Latin America 30 | Discussion |
08:00-09:30 | Room 6 - Rafael Gomez-Cuevas | FLASO MEETING: OBESIDAD: FACTORES ETIOLÓGICOS Y COMPLICACIONES (EN ESPAÑOL) *Activity supported by Novo Nordisk 20 | Alteraciones del microbioma y obesidad: de la teoría a la relevancia práctica 20 | La Fisiología del Tejido Adiposo y supervivencia según el contexto ambientalSpeaker: Julio C Montero (Argentina) 20 | Obesidad y cáncer 20 | El aporte profesional al estigma de la obesidad: una conversación global 10 | Discusion |
08:00-09:30 | Room 4 - Peter Kopelman | SESSION: OBESITY IMPACT ON OTHER ORGANS 08 | Abstracts - 128804: MOLECULAR CHARACTERISATION OF OBESITY BY MEASURING METABOLOMIC CHANGES AFTER WEIGHT LOSS - Presenter: Madeleine L Smith 20 | Obesity nephropathy: what do we know about it? 20 | Obesity, cognitive decline and dementia: mechanisms of neurodegeneration and new insights 20 | The impact of obesity on lung diseases: much more than Sleep ApneaSpeaker: Geraldo Lorenzi Filho (SP) 22 | Discussion |
09:30-10:30 | Room 1 - Alfredo Halpern | KEYNOTE LECTURE: ENERGY EXPENDITURE DURING THE LIFE COURSE AND IN THE LAST DECADES Duração: 45 min. 15 | Discussion |
09:30-10:00 | Room 2 - John Waterlow | BREAK |
09:30-10:00 | Room 3 - Bernard Jeanrenaud | BREAK |
09:30-10:30 | Room 4 - Peter Kopelman | SESSION: OBESITY, DIETS AND PLANETARY HEALTH 20 | Population strategies, diet, physical activity, and the environment for the prevention of obesity and NCD´s 20 | Changes to food systems to reduce obesity and minimize the impacts on the natural Earth system 20 | Discussion |
09:30-10:30 | Room 5 - Phillip James | MAIN CONFERENCE: NEUROBIOLOGY OF EATING BEHAVIOR 45 | Molecular and functional genetics of food intake regulation in times of an obesity pandemicSpeaker: Marcelo Rubinstein (Argentina) 15 | Questions |
09:30-10:30 | Room 6 - Rafael Gomez-Cuevas | FLASO MEETING: OBESIDAD: ENFOQUE DEL TRATAMIENTO (IN SPANISH) *Activity supported by Novo Nordisk 20 | Obesidad: ¿estamos en el camino correcto? 20 | Insuficiencia cardiaca y manejo cardiometabólico. Una visión desde la Endocrinología 20 | El riesgo cardiorrenal metabolico |
10:00-11:00 | Room 2 - John Waterlow | MINI CONFERENCE 30 | The role of Intensive Behaviour treatment with new generation anti-obesity medications 30 | Tryglycerides and CVD residual risk reduction: is obesity the missing link? |
10:00-11:00 | Room 3 - Bernard Jeanrenaud | MINI CONFERENCE 30 | Microbiota and obesity: what do we know and what we don´t know 30 | Air pollution as a risk factor for metabolic diseases |
10:30-11:00 | Room 1 - Alfredo Halpern | BREAK |
10:30-11:00 | Room 5 - Phillip James | BREAK |
10:30-11:00 | Room 4 - Peter Kopelman | BREAK |
10:30-11:00 | Room 6 - Rafael Gomez-Cuevas | BREAK |
11:00-12:30 | Room 1 - Alfredo Halpern | SESSION: DIETS IN OBESITY 08 | Abstracts - 129030: ENERGY INTAKE ESTIMATION FROM EATING SENSOR DATA WITH THE AUTOMATIC INGESTION MONITOR V2 (AIM-2) - Presenter: Edward Sazonov 20 | Diet wars: unveiling the carbohydrate-insulin model and energy balance model 20 | Ketogenic diets: friend or foe? 20 | Intermittent fasting and Time Restrictive Feeding: is it superior to caloric restriction? 22 | Discussion |
11:00-12:30 | Room 2 - John Waterlow | SYMPOSIUM: ADDRESSING OBESITY DURING THE LIFE COURSE - PART 1 20 | Treating obesity before and during pregnancy – is it possible to reduce obesity risk in the offspring? 20 | Interventions in early childhood to prevent obesity 20 | Managing obesity in adolescents: balancing metabolic benefits and potential psychological harms 30 | Discussion |
11:00-12:30 | Room 3 - Bernard Jeanrenaud | SYMPOSIUM: SBEM-ABESOCoordinator: Larissa Garcia Gomes (SP) 20 | Precocious puberty/ precocious adrenarche and the risk of obesity 20 | The role of leptin in sexual maturation and fertility 20 | Endocrine Disruptors and obesity: where the evidence stands now? 30 | Discussion |
11:00-12:30 | Room 5 - Phillip James | SESSION: HEALTH TAXES, LABELLING AND ADVANCING A REGULATORY AGENDA FOR OBESITYCoordinator: Boyd Swinburn (New Zealand) 20 | Health taxes and policies 20 | Marketing and labelling 20 | School feeding, environments and PNAE 30 | Discussion |
11:00-12:30 | Room 4 - Peter Kopelman | SYMPOSIUM: HOT TOPIC IN BARIATRIC SURGERY 08 | Abstracts - 128849: LONG-TERM EFFECT OF METABOLIC-BARIATRIC SURGERY ON MORTALITY AND MACRO AND MICROVASCULAR OUTCOMES IN ADULTS WITH OBESITY, METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, AND DIABETES - Presenter: Arunkumar Krishnan 20 | Endoscopic procedures for primary management of obesity and after bariatric surgery – a review of the evidence Speaker: Vitor Brunaldi (SP) 20 | A critical appraisal of bariatric surgery in the elderly 20 | BS, alcohol and opioid abuse 22 | Discussion |
11:00-12:30 | Room 6 - Rafael Gomez-Cuevas | FLASO MEETING: TRATAMIENTO DE LA OBESIDAD (EN ESPAÑOL) *Activity supported by Novo Nordisk 20 | Enfermedad hepática y Cirugía Bariátrica 20 | aGLP-1, punto de encuentro del tratamiento de la diabesidad 20 | Terapia con fármacos combinados en el manejo de la obesidad 20 | Presente y futuro del tratamiento farmacológico de la obesidad |
12:30-14:00 | Room 1 - Alfredo Halpern | BREAK |
12:30-13:30 | Room 2 - John Waterlow | SATELLITE SYMPOSIUM - LILLY : RESTRICTED TO PRESCRIBERS 1 - Is BMI sufficient to diagnose and classify obesity? What options do we have? Speaker:CINTIA CERCATO 2 - Ectopic and visceral fat: what is the real impact? Speaker: CYNTHIA VALÉRIO |
12:30-13:30 | Room 3 - Bernard Jeanrenaud | SATELLITE SYMPOSIUM - MERCK: (RESTRICTED TO PRESCRIBERS) One Size Does Not Fit All - The New Era of Obesity Management: Beyond Weight Loss Palestrante: SEAN WHARTON Palestrante: DANIEL MARTINEZ Palestrante: ALEXANDER KOGLIN BENCHIMOL |
12:30-14:00 | Room 5 - Phillip James | BREAK |
12:30-14:00 | Room 4 - Peter Kopelman | BREAK |
12:30-14:00 | Room 6 - Rafael Gomez-Cuevas | BREAK |
14:00-15:30 | Room 1 - Alfredo Halpern | SESSION: HETEROGENEITY IN RESPONSES TO OBESITY TREATMENT 8 | Abstracts - 129737: INCREASING GLP1-RA EFFICACY BY TARGETING NON-CODING RNA: A COMBINATORY APPROACH TO DEVELOP A MORE EFFECTIVE THERAPEUTIC PARADIGM - Presenter: Riccardo Panella 20 | Predictors of weight loss in incretin-based therapies 20 | What have we learned about the role of genetics in predicting response to obesity interventions? 20 | Energy compensation, metabolic adaptation and physical activity 22 | Discussion |
14:00-15:30 | Room 2 - John Waterlow | SYMPOSIUM: ADDRESSING OBESITY DURING THE LIFE COURSE - PART 2 08 | Abstracts - 129738: BAT DYSFUNCTIONALITY AND DYSMETABOLISM IN DIFFERENT DEGREES OF ADIPOSOPATHY - Presenter: Maria Eduarda Martelli 20 | Addressing and managing metabolic associated hypogonadism in men 20 | Menopause: A Fat-driven Cardiometabolic Transition 20 | Treating obesity in the elderly: insights from LOOK AHEAD 22 | Discussion |
14:00-15:30 | Room 3 - Bernard Jeanrenaud | SESSION: BROWN ADIPOSE TISSUE 08 | Abstracts - 128942: BREASTFEEDING, BROWN ADIPOSE TISSUE AND IL10: IMPACT ON THE THERMOGENESIS OF NEONATES - Presenter: Bruna Bombassaro 20 | microRNAs and the regulation of brown adipose tissue 20 | New mechanistic insights on the control of brown fat function and identity 20 | BAT and circadian rhythms 22 | Discussion |
14:00-15:30 | Room 4 - Peter Kopelman | SESSION: ULTRA-PROCESSED PRODUCTS CONSUMPTION AND OBESITY IN A GLOBALISED FOOD SYSTEM Duração: 20 min. 20 | Accelerating global public health responses to rethink governance in food systems for UPF-control Duração: 20 min. 30 | Discussion |
14:00-15:30 | Room 5 - Phillip James | SESSION: OBESITY AND TYPE 1 DIABETES 08 | Abstracts - 128844: DOES OBESITY CONFER A DIFFERING RISK ON PREGNANCY OUTCOMES IN WOMEN WITH TYPE 1 DIABETES VERSUS TYPE 2 DIABETES? NOVEL DATA FROM AN AUSTRALIAN RETROSPECTIVE STUDY (2010-2019) COMPARING PREGNANCY OUTCOMES STRATIFIED BY BMI CATEGORY IN WOMEN WITH PREGE - Presenter: Xi May Zhen 20 | Size of the problem and using nutrition therapy and exercise therapy for people living with obesity and type 1 diabetes 20 | Pharmacotherapy for people living with obesity and type 1 diabetes 20 | Surgical therapy for people living with obesity and type 1 diabetesSpeaker: Ricardo Vitor Cohen (SP) 22 | Discussion |
14:00-15:30 | Room 6 - Rafael Gomez-Cuevas | SESSION: ABSTRACTS - BASIC SCIENCEJudge: Marciane Milanski (SP) 128786 - THE EFFECTS OF PHOSPHODIESTERASE 4 INHIBITORS ON WEIGHT LOSS AND ENERGY HOMEOSTASIS IN MICE WITH OBESITY INDUCED BY A HIGH-FAT-DIET 129100 - THE ROLE OF MIR-146A E MIR-378 ON C/EBP-Β, IN OBESE INSULIN SENSITIVITY IMPROVEMENT, INDUCED BY PHYSICAL EXERCISE 129583 - EXPLORING THE CULINARY SKILLS AND DIET QUALITY ACROSS DIFFERENT CARDIOMETABOLIC PHENOTYPES: INSIGHTS FROM THE MENU PROJECT - CULINARY MEDICINE AND NUTRITION 129307 - THE GLOBAL DIET QUALITY SCORE WAS ASSOCIATED WITH BODY ADIPOSITY INDICATORS IN PARTICIPANTS OF THE NUTRITIONIST’S HEALTH STUDY - NUTRIHS CagriSema driven weight loss in diet-induced obese rats depends on counter-regulation of weight loss associated reduction in energy expenditure |
15:30-16:30 | Poster Area - Per Bjorntorp | REFRESHMENT BREAK AND POSTER SESSION E-poster 1 E-poster 2 E-poster 3 E-poster 4
access abstracts |
15:30-16:30 | Room 2 - John Waterlow | REFRESHMENT BREAK AND POSTER SESSION |
15:30-16:30 | Room 3 - Bernard Jeanrenaud | REFRESHMENT BREAK AND POSTER SESSION |
15:30-16:30 | Room 5 - Phillip James | REFRESHMENT BREAK AND POSTER SESSION |
15:30-16:30 | Room 4 - Peter Kopelman | REFRESHMENT BREAK AND POSTER SESSION |
15:30-16:30 | Room 6 - Rafael Gomez-Cuevas | REFRESHMENT BREAK AND POSTER SESSION |
16:30-18:00 | Room 2 - John Waterlow | WILLENDORF AND WERTHEIMER AWARD LECTURES Teaching Ravens to Fly Underwater The Protein Leverage Hypothesis |
16:30-18:00 | Room 1 - Alfredo Halpern | CONTROVERSIES: IS THERE SUCH THING AS METABOLICALLY HEALTHY OBESITY? Abstracts - 129733: THE METABOLICALLY HEALTHY OBESITY PHENOTYPE HAS MORE ACTIVATION OF BROWN ADIPOSE TISSUE THAN THE METABOLICALLY UNHEALTHY OBESITY PHENOTYPE - Presenter: Isabela Solar Abstracts - 128419: PREVALENCE AND TRENDS OF THE METABOLICALLY HEALTHY OBESE PHENOTYPE IN AN ARAB POPULATION - Presenter: Nasser Al-Daghri Yes No |
16:30-17:30 | Room 3 - Bernard Jeanrenaud | MEET THE EXPERT: MULTIDISCIPLINARY APPROACH TO CHILDHOOD OBESITY |
16:30-18:30 | Room 5 - Phillip James | SESSION: ADVANCING COMMUNITY-BASED CHILDHOOD OBESITY PREVENTION IN CITIES Opening: Prevention of childhood obesity through community interventions and the role of cities (WOF) Keynote: Shaping healthy urban neighbourhoods for children Breakout session: Identifying barriers and solutions to co-creating community-based interventions Panel: What does it take to shape healthy city environments for children? Closing |
16:30-17:30 | Room 6 - Rafael Gomez-Cuevas | THE IMPACT OF OBESITY TREATMENT BEYOND WEIGHT LOSSSpeaker: João Eduardo Nunes Salles (SP) |
16:30-17:30 | Room 4 - Peter Kopelman | MEET THE EXPERT: SWITCHING DRUGS IN OBESITY TREATMENT: IN WHOM, WHEN AND HOW? |
17:30-18:30 | Room 4 - Peter Kopelman | MEET THE EXPERT: MANAGING LONG TERM COMPLICATIONS OF BARIATRIC SURGERY |
17:30-18:30 | Room 3 - Bernard Jeanrenaud | MEET THE EXPERT: OBESITY TREATMENT IN POPULATION WITH LOWER INCOME |